Skip to main content
Erschienen in: Diabetologia 8/2009

01.08.2009 | Article

Stromal cell-derived factor-1 promotes survival of pancreatic beta cells by the stabilisation of beta-catenin and activation of transcription factor 7-like 2 (TCF7L2)

verfasst von: Z. Liu, J. F. Habener

Erschienen in: Diabetologia | Ausgabe 8/2009

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

Stromal cell-derived factor-1 (SDF-1) is a chemokine produced in stromal tissues in multiple organs. Earlier we reported on levels of SDF-1 and SDF-1 receptor (CXCR4) in the insulin-producing beta cells of the mouse pancreas and determined that the SDF-1/CXCR4 axis is important for beta cell survival through activation of the prosurvival kinase, protein kinase B (AKT). Since AKT is known to modulate the wingless-type MMTV integration site family (WNT) signalling cascade, we examined the effects of SDF-1/CXCR4 on WNT signalling in beta cells and whether this signalling is important for cell survival.

Methods

Activation of downstream WNT signalling (beta-catenin and transcription factor 7-like 2, [TCF7L2]) in response to SDF-1 was examined in the islets of WNT signalling reporter (Tcf-optimal promoter beta-galactosidase) mice and in INS-1 and MIN6 beta cells. Cytoprotection of beta cells by SDF-1 in response to the induction of apoptosis was assessed by caspase 3 and TUNEL assays.

Results

SDF-1 induced WNT signalling in beta cells of isolated islets and in INS-1 cells via CXCR4-mediated activation of Galphai/o-coupled signalling and the phosphatidylinositol 3-kinase/AKT signalling cascade resulting in the inhibition of glycogen synthase kinase 3-beta. The key WNT signalling regulators, beta-catenin and AKT, were activated by SDF-1 at the transcriptional and post-translational levels. Specific inhibition of beta-catenin in the WNT signalling cascade reversed the anti-apoptotic effects of SDF-1.

Conclusions/interpretation

SDF-1 promotes pancreatic beta cell survival via activation of AKT and downstream WNT signalling via the stabilisation and activation of beta-catenin/TCF7L2 transcriptional activators. These findings suggest a mechanism for SDF-1 based glucose-lowering therapies by enhancing beta cell mass through increasing cell survival.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC (2003) Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes 52:102–110PubMedCrossRef Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC (2003) Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes 52:102–110PubMedCrossRef
2.
Zurück zum Zitat Yano T, Liu Z, Donovan J, Thomas MK, Habener JF (2007) Stromal cell derived factor-1 (SDF-1)/CXCL12 attenuates diabetes in mice and promotes pancreatic beta-cell survival by activation of the prosurvival kinase AKT. Diabetes 56:2946–2957PubMedCrossRef Yano T, Liu Z, Donovan J, Thomas MK, Habener JF (2007) Stromal cell derived factor-1 (SDF-1)/CXCL12 attenuates diabetes in mice and promotes pancreatic beta-cell survival by activation of the prosurvival kinase AKT. Diabetes 56:2946–2957PubMedCrossRef
3.
Zurück zum Zitat Burger JA, Kipps TJ (2006) CXCR4 a key receptor in the crosstalk between tumor cells and their microenvironment. Blood 107:1761–1767PubMedCrossRef Burger JA, Kipps TJ (2006) CXCR4 a key receptor in the crosstalk between tumor cells and their microenvironment. Blood 107:1761–1767PubMedCrossRef
4.
Zurück zum Zitat Kucia M, Ratajczak J, Ratajczak MZ (2005) Bone marrow as a source of circulating CXCR4+ tissue-committed stem cells. Biol Cell 97:133–146PubMedCrossRef Kucia M, Ratajczak J, Ratajczak MZ (2005) Bone marrow as a source of circulating CXCR4+ tissue-committed stem cells. Biol Cell 97:133–146PubMedCrossRef
5.
Zurück zum Zitat Ratajczak MZ, Zuba-Surma E, Kucia M, Reca R, Wojakowski W, Ratajczak J (2006) The pleiotropic effects of the SDF-1-CXCR4 axis in organogenesis, regeneration and tumorigenesis. Leukemia 20:1915–1924PubMedCrossRef Ratajczak MZ, Zuba-Surma E, Kucia M, Reca R, Wojakowski W, Ratajczak J (2006) The pleiotropic effects of the SDF-1-CXCR4 axis in organogenesis, regeneration and tumorigenesis. Leukemia 20:1915–1924PubMedCrossRef
6.
Zurück zum Zitat Kryczek I, Wei S, Keller E, Liu R, Zou W (2007) Stroma-derived factor (SDF-1/CXCL12) and human tumor pathogenesis. Am J Physiol Cell Physiol 292:C987–C995PubMedCrossRef Kryczek I, Wei S, Keller E, Liu R, Zou W (2007) Stroma-derived factor (SDF-1/CXCL12) and human tumor pathogenesis. Am J Physiol Cell Physiol 292:C987–C995PubMedCrossRef
7.
Zurück zum Zitat Schober A, Karshovska E, Zernecke A, Weber C (2006) SDF-1alpha-mediated tissue repair by stem cells: a promising tool in cardiovascular medicine? Trends Cardiovasc Med 16:103–112PubMedCrossRef Schober A, Karshovska E, Zernecke A, Weber C (2006) SDF-1alpha-mediated tissue repair by stem cells: a promising tool in cardiovascular medicine? Trends Cardiovasc Med 16:103–112PubMedCrossRef
8.
Zurück zum Zitat Dalakas E, Newsome PN, Harrison DJ, Plevris JN (2005) Hematopoietic stem cell trafficking in liver injury. FASEB J 19:1225–1231PubMedCrossRef Dalakas E, Newsome PN, Harrison DJ, Plevris JN (2005) Hematopoietic stem cell trafficking in liver injury. FASEB J 19:1225–1231PubMedCrossRef
9.
Zurück zum Zitat Nagasawa T, Hirota S, Tachibana K et al (1996) Defects of B cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature 382:635–638PubMedCrossRef Nagasawa T, Hirota S, Tachibana K et al (1996) Defects of B cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature 382:635–638PubMedCrossRef
10.
Zurück zum Zitat Zou YR, Kottmann AH, Kuroda M, Taniuchi I, Littman DR (1998) Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature 393:595–599PubMedCrossRef Zou YR, Kottmann AH, Kuroda M, Taniuchi I, Littman DR (1998) Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature 393:595–599PubMedCrossRef
11.
Zurück zum Zitat Welters HJ, Kulkarni RN (2008) WNT signalling: relevance to beta cell biology and diabetes. Trends Endocrinol Metab 19:349–355PubMedCrossRef Welters HJ, Kulkarni RN (2008) WNT signalling: relevance to beta cell biology and diabetes. Trends Endocrinol Metab 19:349–355PubMedCrossRef
12.
Zurück zum Zitat Kayali AG, van Gunst K, Campbell IL et al (2003) The stromal cell-derived factor-1alpha/CXCR4 ligand–receptor axis is critical for progenitor survival and migration in the pancreas. J Cell Biol 163:859–869PubMedCrossRef Kayali AG, van Gunst K, Campbell IL et al (2003) The stromal cell-derived factor-1alpha/CXCR4 ligand–receptor axis is critical for progenitor survival and migration in the pancreas. J Cell Biol 163:859–869PubMedCrossRef
13.
Zurück zum Zitat Ide A, Kawasaki E, Abiru N et al (2003) Stromal-cell derived factor-1 chemokine gene variant is associated with type 1 diabetes age at onset in Japanese population. Hum Immunol 64:973–978PubMedCrossRef Ide A, Kawasaki E, Abiru N et al (2003) Stromal-cell derived factor-1 chemokine gene variant is associated with type 1 diabetes age at onset in Japanese population. Hum Immunol 64:973–978PubMedCrossRef
14.
Zurück zum Zitat Dubois-Laforgue D, Hendel H, Caillat-Zucman S et al (2001) A common stromal cell-derived factor-1 chemokine gene variant is associated with the early onset of type 1 diabetes. Diabetes 50:1211–1213PubMedCrossRef Dubois-Laforgue D, Hendel H, Caillat-Zucman S et al (2001) A common stromal cell-derived factor-1 chemokine gene variant is associated with the early onset of type 1 diabetes. Diabetes 50:1211–1213PubMedCrossRef
15.
Zurück zum Zitat Aboumrad E, Madec AM, Thivolet C (2007) The CXCR4/CXCL12 (SDF-1) signalling pathway protects non-obese diabetic mouse from autoimmune diabetes. Clin Exp Immunol 148:432–439PubMed Aboumrad E, Madec AM, Thivolet C (2007) The CXCR4/CXCL12 (SDF-1) signalling pathway protects non-obese diabetic mouse from autoimmune diabetes. Clin Exp Immunol 148:432–439PubMed
16.
Zurück zum Zitat Moon RT, Kohn AD, de Ferrari GV, Kaykas A (2004) WNT and beta-catenin signalling: diseases and therapies. Nat Rev Genet 5:691–701PubMedCrossRef Moon RT, Kohn AD, de Ferrari GV, Kaykas A (2004) WNT and beta-catenin signalling: diseases and therapies. Nat Rev Genet 5:691–701PubMedCrossRef
17.
Zurück zum Zitat Moon RT (2005) WNT/beta-catenin pathway. Sci STKE 2005:cm1 Moon RT (2005) WNT/beta-catenin pathway. Sci STKE 2005:cm1
18.
Zurück zum Zitat Tian Q, Jin H, Cui Y, Guo C, Lu X (2005) Regulation of WNT gene expression. Dev Growth Differ 47:273–281PubMedCrossRef Tian Q, Jin H, Cui Y, Guo C, Lu X (2005) Regulation of WNT gene expression. Dev Growth Differ 47:273–281PubMedCrossRef
19.
Zurück zum Zitat Nelson WJ, Nusse R (2004) Convergence of WNT, beta-catenin, and cadherin pathways. Science 303:1483–1487PubMedCrossRef Nelson WJ, Nusse R (2004) Convergence of WNT, beta-catenin, and cadherin pathways. Science 303:1483–1487PubMedCrossRef
20.
Zurück zum Zitat Logan CY, Nusse R (2004) The WNT signaling pathway in development and disease. Annu Rev Cell Dev Biol 20:781–810PubMedCrossRef Logan CY, Nusse R (2004) The WNT signaling pathway in development and disease. Annu Rev Cell Dev Biol 20:781–810PubMedCrossRef
21.
Zurück zum Zitat Gordon MD, Nusse R (2006) WNT signaling: multiple pathways, multiple receptors, and multiple transcription factors. J Biol Chem 281:22429–22433PubMedCrossRef Gordon MD, Nusse R (2006) WNT signaling: multiple pathways, multiple receptors, and multiple transcription factors. J Biol Chem 281:22429–22433PubMedCrossRef
22.
Zurück zum Zitat Liu Z, Habener JF (2008) Glucagon-like peptide-1 activation of TCF7L2-dependent WNT signaling enhances pancreatic beta cell proliferation. J Biol Chem 283:8723–8735PubMedCrossRef Liu Z, Habener JF (2008) Glucagon-like peptide-1 activation of TCF7L2-dependent WNT signaling enhances pancreatic beta cell proliferation. J Biol Chem 283:8723–8735PubMedCrossRef
23.
Zurück zum Zitat Florez JC (2008) Newly identified loci highlight beta cell dysfunction as a key cause of type 2 diabetes: where are the insulin resistance genes? Diabetologia 51:1100–1110PubMedCrossRef Florez JC (2008) Newly identified loci highlight beta cell dysfunction as a key cause of type 2 diabetes: where are the insulin resistance genes? Diabetologia 51:1100–1110PubMedCrossRef
24.
Zurück zum Zitat Luo Y, Cai J, Xue H, Mattson MP, Rao MS (2006) SDF1alpha/CXCR4 signaling stimulates beta-catenin transcriptional activity in rat neural progenitors. Neurosci Lett 398:291–295PubMedCrossRef Luo Y, Cai J, Xue H, Mattson MP, Rao MS (2006) SDF1alpha/CXCR4 signaling stimulates beta-catenin transcriptional activity in rat neural progenitors. Neurosci Lett 398:291–295PubMedCrossRef
25.
Zurück zum Zitat Lacy PE (1994) Pancreatic islet cell transplant. Mt Sinai J Med 61:23–31PubMed Lacy PE (1994) Pancreatic islet cell transplant. Mt Sinai J Med 61:23–31PubMed
26.
Zurück zum Zitat DasGupta R, Fuchs E (1999) Multiple roles for activated LEF/TCF transcription complexes during hair follicle development and differentiation. Development 126:4557–4568PubMed DasGupta R, Fuchs E (1999) Multiple roles for activated LEF/TCF transcription complexes during hair follicle development and differentiation. Development 126:4557–4568PubMed
27.
Zurück zum Zitat Peng SB, Peek V, Zhai Y et al (2005) AKT activation, but not extracellular signal-regulated kinase activation, is required for SDF-1alpha/CXCR4-mediated migration of epitheloid carcinoma cells. Mol Cancer Res 3:227–236PubMed Peng SB, Peek V, Zhai Y et al (2005) AKT activation, but not extracellular signal-regulated kinase activation, is required for SDF-1alpha/CXCR4-mediated migration of epitheloid carcinoma cells. Mol Cancer Res 3:227–236PubMed
28.
Zurück zum Zitat Song WJ, Schreiber WE, Zhong E et al (2008) Exendin-4 stimulation of cyclin A2 in beta-cell proliferation. Diabetes 57:2371–2381PubMedCrossRef Song WJ, Schreiber WE, Zhong E et al (2008) Exendin-4 stimulation of cyclin A2 in beta-cell proliferation. Diabetes 57:2371–2381PubMedCrossRef
29.
Zurück zum Zitat Jia L, Miao C, Cao Y, Duan EK (2008) Effects of WNT proteins on cell proliferation and apoptosis in HEK293 cells. Cell Biol Int 32:807–813PubMedCrossRef Jia L, Miao C, Cao Y, Duan EK (2008) Effects of WNT proteins on cell proliferation and apoptosis in HEK293 cells. Cell Biol Int 32:807–813PubMedCrossRef
30.
Zurück zum Zitat Wieczorek M, Paczkowska A, Guzenda P, Majorek M, Bednarek AK, Lamparska-Przybysz M (2008) Silencing of WNT-1 by siRNA induces apoptosis of MCF-7 human breast cancer cells. Cancer Biol Ther 7:268–274PubMed Wieczorek M, Paczkowska A, Guzenda P, Majorek M, Bednarek AK, Lamparska-Przybysz M (2008) Silencing of WNT-1 by siRNA induces apoptosis of MCF-7 human breast cancer cells. Cancer Biol Ther 7:268–274PubMed
31.
Zurück zum Zitat Wang X, Xiao Y, Mou Y, Zhao Y, Blankesteijn WM, Hall JL (2002) A role for the beta-catenin/T cell factor signaling cascade in vascular remodeling. Circ Res 90:340–347PubMedCrossRef Wang X, Xiao Y, Mou Y, Zhao Y, Blankesteijn WM, Hall JL (2002) A role for the beta-catenin/T cell factor signaling cascade in vascular remodeling. Circ Res 90:340–347PubMedCrossRef
32.
Zurück zum Zitat Papadopoulou S, Edlund H (2005) Attenuated WNT signaling perturbs pancreatic growth but not pancreatic function. Diabetes 54:2844–2851PubMedCrossRef Papadopoulou S, Edlund H (2005) Attenuated WNT signaling perturbs pancreatic growth but not pancreatic function. Diabetes 54:2844–2851PubMedCrossRef
33.
Zurück zum Zitat Ikonomou L, Geras-Raaka E, Raaka BM, Gershengorn MC (2008) Beta-catenin signaling in mesenchymal islet-derived precursor cells. Cell Prolif 41:474–491PubMedCrossRef Ikonomou L, Geras-Raaka E, Raaka BM, Gershengorn MC (2008) Beta-catenin signaling in mesenchymal islet-derived precursor cells. Cell Prolif 41:474–491PubMedCrossRef
34.
Zurück zum Zitat Tian Q, Feetham MC, Tao WA et al (2004) Proteomic analysis identifies that 14-3-3zeta interacts with beta-catenin and facilitates its activation by AKT. Proc Natl Acad Sci U S A 101:15370–15375PubMedCrossRef Tian Q, Feetham MC, Tao WA et al (2004) Proteomic analysis identifies that 14-3-3zeta interacts with beta-catenin and facilitates its activation by AKT. Proc Natl Acad Sci U S A 101:15370–15375PubMedCrossRef
35.
Zurück zum Zitat Fang D, Hawke D, Zheng Y et al (2007) Phosphorylation of beta-catenin by AKT promotes beta-catenin transcriptional activity. J Biol Chem 282:11221–11229PubMedCrossRef Fang D, Hawke D, Zheng Y et al (2007) Phosphorylation of beta-catenin by AKT promotes beta-catenin transcriptional activity. J Biol Chem 282:11221–11229PubMedCrossRef
Metadaten
Titel
Stromal cell-derived factor-1 promotes survival of pancreatic beta cells by the stabilisation of beta-catenin and activation of transcription factor 7-like 2 (TCF7L2)
verfasst von
Z. Liu
J. F. Habener
Publikationsdatum
01.08.2009
Verlag
Springer-Verlag
Erschienen in
Diabetologia / Ausgabe 8/2009
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-009-1384-x

Weitere Artikel der Ausgabe 8/2009

Diabetologia 8/2009 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.